Invesaro

Stocks Health care PACS

NYSE · Health care

PACS Group, Inc. (PACS)

PACS Group, Inc. brought in $5.7B of revenue over the twelve months to September 30, 2026, up 11.0% from a year earlier. Net income was $277.6M, a net margin of 4.9%. At September 30, 2026 it held $115.3M in cash against $272.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.

Free, no password. An email when PACS files with the SEC.

Price
$48.77
-1.67% on the day · November 9, 2026
52-week range $10.31 to $51.68
Market cap
$7.7B
Revenue (last 12 months)
$5.7B
+11.0% year on year
Net margin
4.9%
P/E
40.0
on FY2025 diluted EPS

Key facts about PACS Group, Inc.

Net worth
PACS Group, Inc. has a market value (market cap) of $7.7B at the latest share price, and shareholders' equity of $1.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $5.3B (+29.3% year on year), with net income of $191.5M. Over the 12 months to September 30, 2026: revenue $5.7B, net income $277.6M.
Cash flow
In fiscal 2025 operations brought in $404.2M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
PACS Group, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What PACS Group, Inc. does

PACS Group, Inc. is registered with the SEC under industry code SIC 8051 (Services-Skilled Nursing Care Facilities). Its shares trade on NYSE under the ticker PACS.

Revenue and profit by year

Revenue
FY22: $2.4B $2.4B FY22FY24: $3.1B $3.1B FY24FY24: $4.1B $4.1B FY24FY25: $5.3B $5.3B FY25
Net income
FY22: $150.5M $150.5M FY22FY24: $112.9M $112.9M FY24FY24: $55.8M $55.8M FY24FY25: $191.5M $191.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$5.3B$309.6M$191.5M$1.22n/a
2024$4.1B$123.1M$55.8M$0.38n/a
2024$3.1B$207.8M$112.9M$0.88n/a
2022$2.4B$229.4M$150.5M$1.17n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 25, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 26, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where PACS ranks in Health care

Revenue$5.3B
#64 of 751 in Health care · Top 8%
Revenue growth+29.3%
#137 of 532 in Health care · Top 26%
Net margin3.6%
#176 of 544 in Health care · Top 32%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2025n/a$00%
2024$0.22$33.7M60%
2024$0.62$80.4M71%
2022$0.47$60.3M40%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What PACS Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 3, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 11% to $1.5B versus the same quarter last year; diluted EPS $0.37 versus $0.32.
  2. November 3, 2026
  3. September 21, 2026
    Executive or director change8-KJohn Mitchell retired as Chief Legal Officer of PACS Group and Patrick J. Murphy was appointed to succeed him.
  4. August 7, 2026
  5. August 4, 2026
  6. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.1% to $1.4B versus the same quarter last year; diluted EPS $0.47 versus $0.31.
  7. June 15, 2026
  8. May 11, 2026
  9. May 11, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 11% to $1.4B versus the same quarter last year; diluted EPS $0.50 versus $0.17.
  10. April 28, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 9, 2026. Insider transactions on SEC

Insider trades

What the people running PACS Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $80M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$80M
last 90 days
Net sold
1,745,163
$80M
DateInsiderWhatSharesPriceValueFiling
November 5, 2026 Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner Soldpre-planned (10b5-1) 17,822 $50.60 $901.8K Form 4
November 5, 2026 Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner Soldpre-planned (10b5-1) 1,413 $51.10 $72.2K Form 4
November 4, 2026 Lewis Michelle ReneeChief Accounting Officer Soldpre-planned (10b5-1) 3,172 $50.06 $158.8K Form 4
November 4, 2026 Hancock MarkDirector, 10% owner Soldpre-planned (10b5-1) 174,937 $50.38 $8.8M Form 4
November 4, 2026 Hancock MarkDirector, 10% owner Soldpre-planned (10b5-1) 11,759 $51.44 $604.9K Form 4
November 4, 2026 Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner Soldpre-planned (10b5-1) 4,000 $47.48 $189.9K Form 4
November 4, 2026 Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner Soldpre-planned (10b5-1) 6,197 $48.56 $300.9K Form 4
November 4, 2026 Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner Soldpre-planned (10b5-1) 12,333 $49.60 $611.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PACS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Jason Hulse Murray13G, passive 35.2% 54,626,199 November 14, 2024
Mark Hancock13G, passive 35.2% 54,626,199 November 14, 2024

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 239 managers reported a position.

HolderSharesValueChange on quarter
Fmr LLC6,207,375$264.7M+959,483
BlackRock, Inc.4,155,408$177.2M+380,118
Crewe Advisors LLC3,307,188$141M+553,009
American Century Companies Inc3,108,196$132.5M+1,298,565
Ameriprise Financial Inc1,995,116$85.1M+873,727
Vanguard Portfolio Management LLC1,982,621$84.5M+121,415
Vanguard Capital Management LLC1,843,496$78.6M+38,906
Alyeska Investment Group, L.P.1,539,065$65.6M-1,463,606
Dimensional Fund Advisors LP1,230,728$52.5M+450,569
Geode Capital Management, LLC1,208,670$51.5M+94,927
State Street Corp1,124,145$47.9M+101,129
Royce & Associates LP912,492$38.9M+4,774
Morgan Stanley750,750$32M+96,272
Wellington Management Group Llp664,861$28.3M-19,168
Jane Street Group, LLC583,754$24.9M+235,522
Goldman Sachs Group Inc452,901$19.3M+31,773
Northern Trust Corp449,052$19.1M+7,881
Nuveen, LLC443,484$18.9M-128,619
Arrowstreet Capital, Limited Partnership428,868$18.3M+140,150
Charles Schwab Investment Management Inc385,647$16.4M-9,349

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

12 insiders reported holding 111,065,285 shares in total, about $5.42B at the last price.

HolderSharesAs of
Murray Jason HulseCo-Founder, CEO & Chairman, Director, 10% owner 53,934,866 November 5, 2026
Hancock MarkDirector, 10% owner 53,318,884 November 4, 2026
Jergensen JoshuaPresident & COO 2,456,320 October 14, 2026
Mitchell John ToddChief Legal Officer & Sec. 803,566 May 18, 2026
Lewis Michelle ReneeChief Accounting Officer 340,338 November 4, 2026
Hendrickson Carey PChief Financial Officer 48,426 May 14, 2026
Bingham Trent DeanChief Human Resources Officer 39,649 March 24, 2026
Priegnitz KellyChief Compliance Officer 38,203 March 24, 2026
Dilsaver Evelyn SDirector 36,085 July 1, 2026
Millard JacquelineDirector 20,217 July 1, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PACS

What does PACS Group, Inc. do?

PACS Group, Inc. is a company in the Health care sector, listed on NYSE as PACS. Its shares trade on NYSE under the ticker PACS.

What is PACS Group, Inc.'s net worth?

PACS Group, Inc. has a market value (market cap) of $7.7B at the latest share price, and shareholders' equity of $1.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is PACS Group, Inc. profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $277.6M on revenue of $5.7B, a net margin of 4.9%.

How much revenue does PACS Group, Inc. make?

Over the twelve months to September 30, 2026 PACS Group, Inc. reported revenue of $5.7B. That is 11.0% more than a year earlier.

When did PACS Group, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade from November 9, 2026.

When is PACS Group, Inc.'s next earnings report?

PACS Group, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare PACS with

Compare PACS with any company

Follow PACS

Get an email when PACS Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when PACS files with the SEC.

Where the numbers come from

Financial figures are the values PACS Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.